Table 2.
Stability of developed AG NPs in terms of mean diameter, polydispersity, ζ potential, and residual drug loading (%) (mean ± SD; n = 3).
Parameter | AG NPs | |||
---|---|---|---|---|
After 7 days | After 14 days | After 21 days | After 30 days | |
Size (nm) | 210.8 ± 1.2 | 211.4 ± 2.5 | 212.6 ± 0.8 | 212.9 ± 2.3 |
PDI | 0.10 ± 0.01 | 0.12 ± 0.02 | 0.09 ± 0.01 | 0.10 ± 0.01 |
ζ potential (mV) | -20.5 ± 4.4 | -20.1 ± 2.7 | -21.3 ± 4.8 | -20.2 ± 1.1 |
Residual drug loading (%) | 99.1 ± 0.2 | 98.8 ± 0.4 | 98.8 ± 0.3 | 98.7 ± 0.2 |